The estimated Net Worth of Ronald E Blaylock is at least 4.49 百万$ dollars as of 16 July 2021. Mr. Blaylock owns over 12,500 units of Pfizer stock worth over 173,630$ and over the last 17 years he sold PFE stock worth over 3,966,533$. In addition, he makes 350,000$ as Independent Director at Pfizer.
Ronald has made over 11 trades of the Pfizer stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 12,500 units of PFE stock worth 1,650,250$ on 16 July 2021.
The largest trade he's ever made was buying 13,000 units of Pfizer stock on 6 August 2020 worth over 501,150$. On average, Ronald trades about 1,369 units every 64 days since 2008. As of 16 July 2021 he still owns at least 5,854 units of Pfizer stock.
You can see the complete history of Mr. Blaylock stock trades at the bottom of the page.
Ronald E. Blaylock serves as Independent Director of the Company. Mr. Blaylock founded and managed Blaylock & Company, an investment banking firm. He also held senior management positions at UBS, PaineWebber Group and Citicorp. Director of CarMax, Inc., W.R. Berkley, Corporation, an insurance holding company, and Conyers Park II Acquisition Corp. (a special purpose acquisition company and an affiliate of Centerview Capital). Director of Syncreon U.S., a for-profit private company. Former Director of Urban One, Inc. Member of the Board of Trustees of Carnegie Hall. Member of the Board of Overseers of New York University Stern School of Business. Board Member of Mebane Foundation.
As the Independent Director of Pfizer, the total compensation of Ronald Blaylock at Pfizer is 350,000$. There are 15 executives at Pfizer getting paid more, with Albert Bourla having the highest compensation of 17,929,000$.
Ronald Blaylock is 60, he's been the Independent Director of Pfizer since 2017. There are 10 older and 19 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
Ronald's mailing address filed with the SEC is 12800 TUCKAHOE CREEK PKWY, , RICHMOND, VA, 23238.
Over the last 12 years, insiders at Pfizer have traded over 216,003,942$ worth of Pfizer stock and bought 24,324 units worth 872,198$ . The most active insiders traders include Shantanu Narayen、Ian C Read、James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of 2,169,896$. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth 147,714$.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: